These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37216358)

  • 1. Discovery of novel PARP-1 inhibitors using tandem
    Bhatnagar A; Nath V; Kumar N; Kumar V
    J Biomol Struct Dyn; 2024 Apr; 42(7):3396-3409. PubMed ID: 37216358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
    Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
    J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking and Biological Evaluation for Identification of Potential Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors.
    Zhou Y; Tang S; Chen T; Niu MM
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31766720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation.
    Halder AK; Saha A; Saha KD; Jha T
    J Biomol Struct Dyn; 2015; 33(8):1756-79. PubMed ID: 25350685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure based pharmacophore study to identify possible natural selective PARP-1 trapper as anti-cancer agent.
    Kumar C; P T V L; Arunachalam A
    Comput Biol Chem; 2019 Jun; 80():314-323. PubMed ID: 31078910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophore based virtual screening for identification of effective inhibitors to combat HPV 16 E6 driven cervical cancer.
    Mohan A; Krishnamoorthy S; Sabanayagam R; Schwenk G; Feng E; Ji HF; Muthusami S
    Eur J Pharmacol; 2023 Oct; 957():175961. PubMed ID: 37549730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unveiling the mechanistic roles of chlorine substituted phthalazinone-based compounds containing chlorophenyl moiety towards the differential inhibition of poly (ADP-ribose) polymerase-1 in the treatment of lung cancer.
    Okunlola FO; Olotu FA; Soliman MES
    J Biomol Struct Dyn; 2022; 40(21):10878-10886. PubMed ID: 34463214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel PARP-1 Inhibitor Scaffolds Disclosed by a Dynamic Structure-Based Pharmacophore Approach.
    Baptista SJ; Silva MM; Moroni E; Meli M; Colombo G; Dinis TC; Salvador JA
    PLoS One; 2017; 12(1):e0170846. PubMed ID: 28122037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leveraging shape screening and molecular dynamics simulations to optimize PARP1-Specific chemo/radio-potentiators for antitumor drug design.
    Khizer H; Maryam A; Ansari A; Ahmad MS; Khalid RR
    Arch Biochem Biophys; 2024 Jun; 756():110010. PubMed ID: 38642632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active site fingerprinting and pharmacophore screening strategies for the identification of dual inhibitors of protein kinase C (ΡΚCβ) and poly (ADP-ribose) polymerase-1 (PARP-1).
    Chadha N; Silakari O
    Mol Divers; 2016 Aug; 20(3):747-61. PubMed ID: 27216445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-silico method for elucidation of prodigiosin as PARP-1 inhibitor a prime target of Triple-negative breast cancer.
    Sundararajan P; Dharmaraj Rajaselvi D; Vivekananthan S; Priya Ramasamy S
    Bioorg Chem; 2023 Sep; 138():106618. PubMed ID: 37244231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AI-based prediction of new binding site and virtual screening for the discovery of novel P2X3 receptor antagonists.
    Kang KM; Lee I; Nam H; Kim YC
    Eur J Med Chem; 2022 Oct; 240():114556. PubMed ID: 35849939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Silico Discovery of Novel Flavonoids as Poly ADP Ribose Polymerase (PARP) Inhibitors.
    Shah A; Parmar G; Seth AK
    Curr Comput Aided Drug Des; 2021; 17(3):344-350. PubMed ID: 32268868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated support vector machine and pharmacophore based virtual screening driven identification of thiophene carboxamide scaffold containing compound as potential PARP1 inhibitor.
    Singh M; Rajawat J; Kuldeep J; Shukla N; Mishra DP; Siddiqi MI
    J Biomol Struct Dyn; 2022 Nov; 40(18):8494-8507. PubMed ID: 33950778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and
    Guleria M; Kumar A; Singh AK; Kumar P
    Comb Chem High Throughput Screen; 2024; 27(9):1329-1343. PubMed ID: 37691193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Novel Apigenin-Piperazine Hybrids as Potent and Selective Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors for the Treatment of Cancer.
    Long H; Hu X; Wang B; Wang Q; Wang R; Liu S; Xiong F; Jiang Z; Zhang XQ; Ye WC; Wang H
    J Med Chem; 2021 Aug; 64(16):12089-12108. PubMed ID: 34404206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico investigation of PARP-1 catalytic domains in holo and apo states for the design of high-affinity PARP-1 inhibitors.
    Salmas RE; Unlu A; Yurtsever M; Noskov SY; Durdagi S
    J Enzyme Inhib Med Chem; 2016; 31(1):112-20. PubMed ID: 26083304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mechanisms of PARP-1 Inhibitor 7-Methylguanine.
    Nilov D; Maluchenko N; Kurgina T; Pushkarev S; Lys A; Kutuzov M; Gerasimova N; Feofanov A; Švedas V; Lavrik O; Studitsky VM
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design of new poly (ADP-ribose) polymerase (PARP-1) inhibitors.
    Chadha N; Jaggi AS; Silakari O
    Mol Divers; 2017 Aug; 21(3):655-660. PubMed ID: 28653128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.